TickerKhojComparison · NSE · data 2026-11-02
Mangalam Drugs & Organics Ltd. vs Onyx Biotec Ltd.
In plain words
Size: Onyx Biotec Ltd. is about 1.4 times the market value of Mangalam Drugs & Organics Ltd..
Return on equity: Onyx Biotec Ltd. -0.4% vs Mangalam Drugs & Organics Ltd. -35.2%.
Debt to equity: Mangalam Drugs & Organics Ltd. 1.08 vs Onyx Biotec Ltd. 0.27.
Differences in the numbers, not a recommendation of either stock.
Side by side
| MANGALAM | ONYX | |
|---|---|---|
| Price | ₹29 | ₹36 |
| Market cap | ₹46 cr | ₹65 cr |
| P/E | — | — |
| P/B | — | — |
| ROE | -35.2% | -0.4% |
| ROCE | -22.8% | 0.5% |
| Debt / equity | 1.08 | 0.27 |
| Operating margin | -11.5% | 0.5% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | -14.7% | 20.7% |
| Profit growth, 3 years (yearly) | — | — |
| 1-year return | -56.0% | -12.4% |
| Revenue, last 12 months | ₹232 cr | ₹69 cr |
| Net profit, last 12 months | ₹-38 cr | ₹-0 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹-8 cr | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 35.65% | — |
| Health check | Weak (0/10) | Weak (3.3/10) |
Common questions
Which earns a higher return on equity?
Onyx Biotec Ltd. (-0.4% against -35.2%).
Which carries more debt?
Mangalam Drugs & Organics Ltd. has the higher debt-to-equity ratio (1.08 against 0.27).